Steve Aselage, Director at Travere Therapeutics, Inc. (TVTX), sold 60,000 shares at $26.23 ($1.6M) on 2021-10-07, disclosed to the SEC on 2021-10-08.
Open-market sale of $1.6M TVTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.23 | 28,000 | $734K | 46.6% |
| 2 | $26.26 | 32,000 | $840K | 53.4% |
| Total | $26.25 avg | 60,000 | $1.6M | 100% |
| Filing → |
| TVTX | SELL | 2022-05-12 | $113K | — | Filing → |
| ACER | BUY | 2021-12-13 | $21K | — | Filing → |
| TVTX | SELL | 2021-11-18 | $935K | — | Filing → |